山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
48期
16-18
,共3页
肺肿瘤%肺癌细胞%微小核糖核酸%转移
肺腫瘤%肺癌細胞%微小覈糖覈痠%轉移
폐종류%폐암세포%미소핵당핵산%전이
lung tumor%lung cancer cell%micro RNA%metastasis
目的:观察肺癌细胞及组织中 miR-181a、miR-200a、miR-200c 的表达变化,并探讨其临床意义。方法选择人肺癌细胞系NCI-H1299、NCI-H358、H460、A549及人正常支气管上皮细胞HBE,10例肺癌患者的癌组织及其相应癌旁组织。采用RT-PCR法检测各细胞系及组织中的miR-181a、miR-200a、miR-200c,并分析miRNA表达与临床参数的关系。结果 NCI-H1299、NCI-H358、A549细胞中miR-181a相对表达量均低于HBE细胞,NCI-H1299、NCI-H358、H460、A549细胞中miR-200a相对表达量均低于HBE细胞,NCI-H358、H460细胞中miR-200c相对表达量均高于HBE细胞,P均<0.05。肺癌及癌旁组织中miR-181a和miR-200a相对表达量比较,P均>0.05;肺癌组织中miR-200c相对表达量高于癌旁组织,P<0.01。有淋巴结转移的肺癌患者miR-200a相对表达量低于无淋巴结转移者,P<0.01;其余miRNA相对表达量与临床病理参数均无关,P均>0.05。结论 miR-181a、miR-200a在肺癌细胞株中表达普遍降低,而miR-200c在肺癌细胞及组织中表达普遍升高,可能与肺癌的发病有关。
目的:觀察肺癌細胞及組織中 miR-181a、miR-200a、miR-200c 的錶達變化,併探討其臨床意義。方法選擇人肺癌細胞繫NCI-H1299、NCI-H358、H460、A549及人正常支氣管上皮細胞HBE,10例肺癌患者的癌組織及其相應癌徬組織。採用RT-PCR法檢測各細胞繫及組織中的miR-181a、miR-200a、miR-200c,併分析miRNA錶達與臨床參數的關繫。結果 NCI-H1299、NCI-H358、A549細胞中miR-181a相對錶達量均低于HBE細胞,NCI-H1299、NCI-H358、H460、A549細胞中miR-200a相對錶達量均低于HBE細胞,NCI-H358、H460細胞中miR-200c相對錶達量均高于HBE細胞,P均<0.05。肺癌及癌徬組織中miR-181a和miR-200a相對錶達量比較,P均>0.05;肺癌組織中miR-200c相對錶達量高于癌徬組織,P<0.01。有淋巴結轉移的肺癌患者miR-200a相對錶達量低于無淋巴結轉移者,P<0.01;其餘miRNA相對錶達量與臨床病理參數均無關,P均>0.05。結論 miR-181a、miR-200a在肺癌細胞株中錶達普遍降低,而miR-200c在肺癌細胞及組織中錶達普遍升高,可能與肺癌的髮病有關。
목적:관찰폐암세포급조직중 miR-181a、miR-200a、miR-200c 적표체변화,병탐토기림상의의。방법선택인폐암세포계NCI-H1299、NCI-H358、H460、A549급인정상지기관상피세포HBE,10례폐암환자적암조직급기상응암방조직。채용RT-PCR법검측각세포계급조직중적miR-181a、miR-200a、miR-200c,병분석miRNA표체여림상삼수적관계。결과 NCI-H1299、NCI-H358、A549세포중miR-181a상대표체량균저우HBE세포,NCI-H1299、NCI-H358、H460、A549세포중miR-200a상대표체량균저우HBE세포,NCI-H358、H460세포중miR-200c상대표체량균고우HBE세포,P균<0.05。폐암급암방조직중miR-181a화miR-200a상대표체량비교,P균>0.05;폐암조직중miR-200c상대표체량고우암방조직,P<0.01。유림파결전이적폐암환자miR-200a상대표체량저우무림파결전이자,P<0.01;기여miRNA상대표체량여림상병리삼수균무관,P균>0.05。결론 miR-181a、miR-200a재폐암세포주중표체보편강저,이miR-200c재폐암세포급조직중표체보편승고,가능여폐암적발병유관。
Objective To observe the expression and significance of miR-181a, miR-200a, miR-200c in lung cancer tissues and cells.Methods RT-PCR method was used to detect the expression of miR-181a, miR-200a, miR-200c in lung cancer cell lines NCI-H1299, NCI-H358, H460, A549 and normal human bronchial epithelial cell line HBE , and in the lung cancer tissues and adjacent tissues .To analyze the relationship between the expression of miR-181a, miR-200a, miR-200c and clinicopathological parameters of lung cancer by means of Mann-Whitney.Results miR-181a expression in NCI-H1299, NCI-H358 and A549 were lower than that in HBE (all P<0.05).miR-200a expression in NCI-H1299, NCI-H358, H460 and A549 were lower than that in HBE (all P<0.05).miR-200c expression in NCI-H358 and H460 were higher than that in HBE (all P<0.05).The expression of miR-181a and miR-200a were no significant differences between lung cancer tissues and cancer-adjacent tissues (all P>0.05).miR-200c expression in lung cancer tissues was higher than that in cancer-adjacent tissues (P<0.01).miR-200a expression in the lung cancer patients with lymphatic metastasis was lower than that in lung cancer patients without lymphatic metastasis (P<0.01).Conclusions The expression of miR-181a, miR-200a were generally decreased , while miR-200c was generally increased in lung cancer cell lines and tissues , which maight be related to the occur of lung cancer .